OLN: A Bounce Above 15.50 Still Has to Prove It Can Hold 16.03Olin CorporationBATS:OLNSmalldikenergyOlin's completed Friday, October 16 daily candle opened at 15.61, reached 16.03, traded down to 15.48 and closed at 15.65, up 0.64%. The body was positive, but only 0.04 separated the open and close. The upper wick reached the next recovery reference and the close remained below it. That is a modest positive session within a visible decline, not a confirmed reversal of the preceding downtrend. The Fibonacci map uses the September 9 rebound high of 18.29 and the October 13 low of 14.64. The September anchor is a visible local rebound peak followed by lower prices; the October anchor is the later low, slightly below October 12's 14.65. Using the actual wick extremes keeps the measured 3.65 range tied to identifiable candles. These anchors describe this selected decline. They do not prove that the low is permanent, and a new lower low would require a fresh map. Measured upward from 14.64, the recovery ladder is 15.50 at 23.6%, 16.03 at 38.2%, 16.47 at the halfway mark, 16.90 at 61.8% and 17.51 at 78.6%, followed by the original 18.29 high. The displayed levels are rounded to cents. The halfway line is a common charting convention, not a Fibonacci ratio. It can organize a test without gaining predictive certainty from its label. The immediate decision is the 15.50–16.03 area. Friday briefly traded below the lower reference and recovered it by the close, while its high reached 16.03. A constructive next sequence would retain 15.50, break above 16.03 and then hold that area on a separate return test. That held retest matters: a wick through resistance or an opening gap alone does not show that buyers can defend the recovery. If that sequence develops, 16.47 becomes the next comparison, followed by 16.90. Those are conditional checkpoints, not moves already observed. The 55 EMA remains above price at approximately 17.42 and slopes lower on this daily view. It sits near the 17.51 retracement reference, creating a later area to inspect if the nearer recovery steps succeed. The average will evolve with new candles. It should not be treated as a fixed price that guarantees either support or rejection. Recovering 16.03 while remaining below a declining average would still leave a distinction between a short-term bounce and broader trend repair. RSI is 43.48, above the displayed smoothing line near 35.52 but below 50. That is consistent with an improving bounce while momentum remains below its midpoint. It is not an independent buy instruction. Nor does this single RSI reading establish bullish divergence; that would require comparing identified price and momentum swings on the same timeframe. The weaker route is a loss of 15.50 followed by an unsuccessful reclaim. That would undermine the immediate recovery attempt and bring the 14.64 low back into focus. A break below 14.64 would invalidate a plan that assumes this low is defended. Extending the selected 3.65 decline by 27.2% below its low gives approximately 13.65, shown as a conditional downside reference rather than an inevitable destination. A sustained recovery above 16.03 would weaken an immediate rejection interpretation; it would still need the next price tests before a larger reversal claim. Westlake and Tronox are related chemical/materials context for the discussion, not identical businesses or evidence that their charts have passed Olin's levels. The plan here is limited to the pictured daily structure. Weekend reference levels cannot substitute for the next session's actual spreads, gaps and trading behavior. Position risk depends on entry, invalidation, size and execution; no position or fill is claimed. Which would give you more useful confirmation here: a brief push through 16.03, or a break followed by a separate retest that holds it—and what would make you reject that interpretation? Business and macro context: Olin combines chemical businesses with Winchester. Those activities do not share one uniform demand driver. Interest-rate and input-cost changes can affect financing, customer investment and valuation assumptions, but this chart does not establish an earnings cause for any candle. Read business evidence separately from the conditional price tests above.